Oncothyreon Inc (USA) news

   Watch this stock
Showing stories 1 - 10 of about 79   

Articles published

ONTY 1.60 -0.03 (-2.15%)
price chart
Analyst Rating Update on Oncothyreon Inc (USA)
Analysts at Zacks have given a short term rating of hold on Oncothyreon Inc (NASDAQ:ONTY) with a rank of 3. The counter has received an average rating of 1.67 from 3 brokerage firms.
Price Target Update on Oncothyreon Inc (USA)  Bar and Graph Report
Oncothyreon Inc (USA) Short Interest Drops by -1.1%
Oncothyreon Inc (USA) (NASDAQ:ONTY), A sharp reduction of 49,679 shares or 1.1% was observed in the short interest of Oncothyreon Inc. - Common Shares The interest on January 30,2015 came in at 4,696,687 shares and as per the average daily ...
Oncothyreon Inc (USA) Price Target Update
Oncothyreon Inc (USA) (NASDAQ:ONTY): 2 analysts have set the short term price target of Oncothyreon Inc (USA) (NASDAQ:ONTY) at $4. The standard deviation of short term price target has been estimated at $0, implying that the actual price may fluctuate ...
Oncothyreon Inc (USA) Analyst Rating Update  Wall Street Pulse
Oncothyreon Inc (USA) Receives Average Target Price of $4
Oncothyreon Inc (USA) (NASDAQ:ONTY) should head towards $4 per share according to 2 Analysts in consensus. However, if the road gets shaky, the stock may fall short to $4 per share.
First Call Rating Update on Oncothyreon Inc (USA)
Oncothyreon Inc (USA) (NASDAQ:ONTY): 2 analysts have set the short term price target of Oncothyreon Inc (USA) (NASDAQ:ONTY) at $4. The standard deviation of short term price target has been estimated at $0, implying that the actual price may fluctuate ...
Zacks Long Term Rating Update on Oncothyreon Inc (USA)
As much as 3 analysts have advised buy on Oncothyreon Inc (USA) (NASDAQ:ONTY) with an average broker rating of 1.67.
Company Shares of Oncothyreon Inc (USA) Drops by -5.06%
Oncothyreon Inc (USA) (NASDAQ:ONTY) has lost 5.06% during the past week and dropped 10.18% in the past 4 weeks. The shares are however, marginally negative as compared to the S&P 500 for the past week with a loss of 7.86%.
Oncothyreon Inc (USA) (ONTY): Oncothyreon Offers Income To Those Accepting ...
Oncothyreon Inc. (NASDAQ:ONTY) is a biotechnology corporation that dedicates its available resources to treatments for cancer.
Related articles »  
Company Shares of Oncothyreon Inc (USA) Drops by -1.27%
Oncothyreon Inc (USA) (NASDAQ:ONTY) has dropped 1.27% during the past week, however, the bigger picture is still very bullish; the shares have posted positive gains of 1.31% in the last 4 weeks.
Pharma Stocks To Keep An Eye On: Pozen Inc. (POZN), Paratek ...
Breaking its losing streak from the past few days, the market was finally up in Wednesday's trading session, with all sectors ending in the green.
Related articles »